Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | WVE | AMGN | VRTX | REGN | BMY |
| Company | Wave Life Sci Ord Sh | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.95 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 5.30 | 276.75 | 397.97 | 901.30 | 44.47 |
| Low | 4.95 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 5.26 | 276.58 | 397.17 | 899.20 | 44.21 |
| Change | +0.33 | +2.64 | +4.36 | +8.54 | +0.27 |
| % Change | +6.69% | +0.96% | +1.11% | +0.96% | +0.61% |
| Volume | 308,067 | 551,871 | 222,226 | 136,065 | 4,903,247 |
| 20-Day Average Volume | 490,411 | 2,150,740 | 946,538 | 452,732 | 13,633,623 |
| Previous Close | 4.93 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.30 | 269.63 | 398.60 | 908.86 | 48.21 |
| 20-Day Raw Stochastic | 39.49% | 95.86% | 23.20% | 26.34% | 4.48% |
| 20-Day Relative Strength | 48.53% | 51.74% | 42.51% | 40.39% | 28.04% |
| Weighted Alpha | +6.16 | +13.89 | +12.37 | +16.21 | -36.44 |
| Today's Opinion | 24% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 8% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 72% Buy | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.39% since 04/24/24 | +1.16% since 04/24/24 | -1.18% since 04/24/24 | -0.93% since 04/24/24 | -9.73% since 04/24/24 |
| Low | 4.64 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 5.30 on 05/01/24 | 276.86 on 04/29/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -17.12% since 04/01/24 | -2.42% since 04/01/24 | -5.82% since 04/01/24 | -7.34% since 04/01/24 | -16.77% since 04/01/24 |
| Low | 4.64 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 6.30 on 04/02/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | +30.75% since 02/01/24 | -14.90% since 02/01/24 | -8.72% since 02/01/24 | -6.23% since 02/01/24 | -9.38% since 02/01/24 |
| Low | 3.50 on 02/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 7.67 on 03/07/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -1.32% since 11/01/23 | +5.88% since 11/01/23 | +7.23% since 11/01/23 | +13.51% since 11/01/23 | -13.99% since 11/01/23 |
| Low | 3.50 on 02/14/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 7.67 on 03/07/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 602,860 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 122,284 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 113,310,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -57,510,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 29,060,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -16,260,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | -1.12 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 03/06/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |